| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE | 10 |
| 1 | METHOTREXATE SODIUM | 10 |
| 2 | PREDNISOLONE | 8 |
| 3 | PREDNISOLONE ORAL | 8 |
| 4 | PREDNISOLONE ORAL SOLUTION | 8 |
| 5 | TESTOSTERONE | 8 |
| 6 | CYCLOPHOSPHAMIDE | 5 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 5 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 5 |
| 9 | CYTARABINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAFARELIN ACETATE | 1 | 0.0037 |
| 1 | NIROGACESTAT | 1 | 0.0011 |
| 2 | FLURBIPROFEN | 1 | 0.0007 |
| 3 | ESTROGEN | 1 | 0.0003 |
| 4 | TESTOSTERONE | 8 | 0.0003 |
| 5 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| 6 | THIOTEPA | 2 | 0.0002 |
| 7 | MERCAPTOPURINE | 3 | 0.0002 |
| 8 | TESTOSTERONE CYPIONATE | 1 | 0.0001 |
| 9 | IFOSFAMIDE FOR INJECTION | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 1 | Alkylating Drug [EPC] | 8 |
| 2 | Androgen [EPC] | 8 |
| 3 | Corticosteroid [EPC] | 8 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 5 |
| 5 | Topoisomerase Inhibitor [EPC] | 4 |
| 6 | Atypical Antipsychotic [EPC] | 3 |
| 7 | Estrogen [EPC] | 2 |
| 8 | Copper-containing Intrauterine Device [EPC] | 1 |
| 9 | Gamma Secretase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 1 | Androgen [EPC] | 8 | 0.0003 |
| 2 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 3 | Alkylating Drug [EPC] | 8 | 0.0000 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 10 | 0.0000 |
| 5 | Copper-containing Intrauterine Device [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 7 | Estrogen [EPC] | 2 | 0.0000 |
| 8 | Atypical Antipsychotic [EPC] | 3 | 0.0000 |
| 9 | Corticosteroid [EPC] | 8 | 0.0000 |